Top Section/Ad
Top Section/Ad
Most recent
Investors saw plenty of juice in first public AT1 from Chile as regulatory framework draws praise
Mexican lender falls short of bond size target as late 2023 momentum fades
◆ US RMBS sales in Europe: immigration or vacation? ◆ UBS AT1 makes nonsense of claims of investor fears ◆ The EU's last hurrah in the SSA market
◆ IG investors comfort eat sweet spreads ◆ What can FIG issuers do now? ◆ US HEI securitizations: mainstream or flash in pan?
More articles/Ad
More articles/Ad
More articles
-
Erste Group Bank is preparing to sell its third additional tier one bond as part of a deal that would reopen the market for the first time in nearly a month.
-
KDB Life Insurance Co bagged a $200m subordinated trade on Monday in its first foray into the international bond market, getting away with the structure despite a volatile backdrop -
Hedge fund Caius Capital caused a stir this week with its assertion that a swathe of UniCredit’s capital is receiving the wrong regulatory treatment. The bank resoundingly denied it was in trouble, but the dispute has shone a light on the unclear complexity of the treatment of legacy instruments.
-
The initial public offering for Axa’s US business raised less than targeted. This prompted market debate about whether the French insurer is on track in raising cash for its acquisition of XL Group and whether it would need to raise more debt, something denied by the insurer.
-
Hedge fund Caius Capital has written to the European Banking Authority claiming that a legacy equity-linked instrument issued by UniCredit counts incorrectly as regulatory capital. The fund believes this makes the bank’s ordinary shares ineligible as capital too.
-
Sydbank is preparing to sell its first additional tier one bond in the euro market, complementing plans to optimise its capital structure via share buy-backs.
